H
Howard N. Hodis
Researcher at University of Southern California
Publications - 318
Citations - 24700
Howard N. Hodis is an academic researcher from University of Southern California. The author has contributed to research in topics: Menopause & Intima-media thickness. The author has an hindex of 74, co-authored 297 publications receiving 22233 citations. Previous affiliations of Howard N. Hodis include Oklahoma Medical Research Foundation.
Papers
More filters
Journal ArticleDOI
Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.
Jamaica R. Rettberg,Ha Dang,Howard N. Hodis,Victor W. Henderson,Jan A. St. John,Wendy J. Mack,Roberta Diaz Brinton +6 more
TL;DR: This panel of well-established clinical peripheral biomarkers represents an initial step toward developing an affordable, rapidly deployable, and clinically relevant strategy to detect an at-risk phenotype of late-onset Alzheimer's disease.
Journal ArticleDOI
Estradiol Therapy After Menopause Mitigates Effects of Stress on Cortisol and Working Memory
TL;DR: Evidence is presented suggesting ET may protect certain types of cognition in the presence of stress, and estrogenic protection against stress hormone exposure may prove beneficial to both cognition and the neural circuitry that maintains and propagates cognitive faculties.
Journal ArticleDOI
Prenatal Air Pollution Exposure and Early Cardiovascular Phenotypes in Young Adults.
Carrie V. Breton,Wendy J. Mack,Jin Yao,Kiros Berhane,Milena Amadeus,Fred Lurmann,Frank D. Gilliland,Rob McConnell,Howard N. Hodis,Nino Künzli,Nino Künzli,Edward L. Avol +11 more
TL;DR: Prenatal exposure to elevated air pollutants may increase carotid arterial stiffness in a young adult population of college students and efforts aimed at limiting prenatal exposures are important public health goals.
Journal ArticleDOI
Hormone replacement therapy - where are we now?
TL;DR: Hormone replacement therapy (HRT) was the standard of care for menopause management until 2002, when perceptions changed following release of the initial results from the Women's Health Initiative (WHI) trial as mentioned in this paper.
Journal ArticleDOI
Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
Jason D. Barbour,Jason D. Barbour,Emilie Jalbert,Emilie Jalbert,Dominic C. Chow,Dominic C. Chow,Louie Mar A Gangcuangco,Louie Mar A Gangcuangco,Philip J. Norris,Philip J. Norris,Sheila M. Keating,Sheila M. Keating,John W. Heitman,Lorna S. Nagamine,Todd B. Seto,Todd B. Seto,Lishomwa C. Ndhlovu,Lishomwa C. Ndhlovu,Beau K. Nakamoto,Beau K. Nakamoto,Howard N. Hodis,Nisha I. Parikh,Nisha I. Parikh,Cecilia M. Shikuma,Cecilia M. Shikuma +24 more
TL;DR: A biostatistical analysis and screen of candidate cellular and plasma biomarkers for association with carotid artery intima-media thickness (CIMT) in HIV-1 infected adults, independent of traditional CVD risk factors such as age, gender, systolic blood pressure (SBP), lipid levels, smoking and diabetes.